SCNI

Scinai Immunotherapeutics Ltd. - American Depositary Shares (SCNI)

About Scinai Immunotherapeutics Ltd. - American Depositary Shares (SCNI)

Scinai Immunotherapeutics Ltd. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunomodulation therapies for infectious diseases. It focuses on the flu vaccine candidate that was designed to provide multi-strain and multi-season protection against seasonal and pandemic influenza. The company was founded by Ronald Babecoff and Rami Epstein on July 21, 2003 and is headquartered in Jerusalem, Israel.

Details

Daily high

$0.25

Daily low

$0.22

Price at open

52 Week High

$3.48

52 Week Low

$0.21

Market cap

989,200

Dividend yield

0.00%

Volume

21,176

Avg. volume

607,730

P/E ratio

-.04

Scinai Immunotherapeutics Ltd. - American Depositary Shares News